β-Cyclodextrin-based biodegradable dendrimers for drug delivery

J Control Release. 2011 Nov 30:152 Suppl 1:e89-90. doi: 10.1016/j.jconrel.2011.08.142.

Authors

Jianbin Tang¹, Xingping Wang, Xinping Wang, Meihua Sui, Weiwei Mao, Youqing Shen

Affiliation

¹ Department of Chemical & Biological Engineering, and Center of Bionanoengineering, Zhejiang University, Hangzhou 310027, China.

PMID: 22195948
DOI: 10.1016/j.jconrel.2011.08.142

No abstract available

MeSH terms

Animals
Antimetabolites, Antineoplastic / chemistry*
Antimetabolites, Antineoplastic / metabolism
Antimetabolites, Antineoplastic / pharmacology
Breast Neoplasms / metabolism
Breast Neoplasms / pathology
Cell Line, Tumor
Cell Survival / drug effects
Chemistry, Pharmaceutical
Chromatography, Gel
Dendrimers*
Dose-Response Relationship, Drug
Drug Carriers*
Drug Compounding
Female
Humans
Inhibitory Concentration 50
Kinetics
Lysosomes / metabolism
Magnetic Resonance Spectroscopy
Methotrexate / chemistry*
Methotrexate / metabolism
Methotrexate / pharmacology
Micelles
Microscopy, Fluorescence
Particle Size
Polyethylene Glycols / chemistry*
Solubility
Technology, Pharmaceutical / methods
beta-Cyclodextrins / chemistry*

Substances

Antimetabolites, Antineoplastic
Dendrimers
Drug Carriers
Micelles
beta-Cyclodextrins
Polyethylene Glycols
Methotrexate